Podcast Summary: The Rundown
Host: Zaid Admani
Date: October 1, 2025
Episode Title: Nike Ends Sales Growth Losing Streak, Pfizer Strikes Medicaid Deal with Trump
Duration: ~10 minutes
Overview
This episode of The Rundown delivers a concise, energetic briefing on the day’s stock market and business headlines. Host Zaid Admani covers the government shutdown’s market impact, Nike’s surprise return to sales growth, Pfizer’s major drug pricing deal with President Trump, and sharp moves in prominent stocks. The episode wraps up with a fun revelation about Bad Bunny’s Super Bowl halftime show payout.
Key Discussion Points & Insights
1. Market Update & Government Shutdown
[00:39]
- September ended strong: S&P 500 up 0.4%, NASDAQ up 0.3%, Dow up 0.2% at record highs.
- “But you know, nobody cares about the Dow.” (Zaid, 00:44)
- September was the best since 2010; five-month market winning streak.
- Q4 begins with uncertainty as the US government shuts down after failing to pass a budget.
- Historical context: market reactions to shutdowns have been minor if short-lived, but this one may last longer due to persistent political gridlock.
- Investor response:
- Flight to safety—gold price jumped to a record $3,900/oz.
- “Gold is considered a safe haven… which I think is a fair description of what’s happening right now.” (Zaid, 02:07)
- Flight to safety—gold price jumped to a record $3,900/oz.
2. Nike’s Comeback: Q3 Earnings Recap
[02:39]
- Nike posts first sales growth in over a year: revenues up 1% to $11.7B, beating Wall Street expectations by $700M.
- Recovery fueled by:
- Reinvigorated wholesale business—sales up 7% after restoring retail partnerships (e.g., Foot Locker, Amazon).
- Running shoes revenue surged 20%.
- Shift away from previous “direct-to-consumer” focus; company moving back to wholesale channels.
- “I think Nike has fully admitted defeat on their direct strategy and now they're reversing course and going back to wholesale.” (Zaid, 03:32)
- Profits still down (–31%) due to ongoing discounts, inventory clearing, and tariff impact.
- Management not expecting stable sales growth until at least 2026.
- Positive outlook lifts Nike stock 5%.
- New CEO Elliot Hill credited for strategic turnaround momentum.
- Memorable analogy:
- “If Nike was a basketball team…they’re about to enter the second quarter down like 15 points, but they just went on a 10–0 run. So still down, but they have some good stuff going for them.” (Zaid, 04:12)
3. Pfizer & Trump Strike Drug Pricing Deal
[05:05]
- Agreement: Medicaid patients to receive “most favored nation” pricing from Pfizer—matching drug prices in other developed countries for new and existing meds.
- Pfizer commits $70B toward US research and manufacturing.
- In exchange, Pfizer gets a 3-year exemption from proposed 100% tariffs on brand-name drugs.
- Context:
- US consumers pay far more for meds than other countries; drug pricing a centerpiece of Trump policy.
- Trump pursuing similar deals with other pharma companies (notably Eli Lilly).
- Launching “Trump Rx” government website in 2026 to sell discounted drugs (50–85% below retail).
- “Wall Street analysts don’t think that this deal will have much of an impact on Pfizer’s bottom line, since Medicaid participants already get a big discount on drugs.” (Zaid, 06:27)
- Pfizer stock up 7%, Eli Lilly up 5%.
- Big picture: This deal offers tariff clarity for pharma investors and may pressure drug prices downward.
4. Stocks on the Move
Lithium Americas
[07:15]
- Shares soar >35% after US government takes a direct 5% stake in the company and the Thacker Pass project.
- Part of Trump administration’s effort to secure battery supply chains.
- “You know, this company stock was trading at like $3 last week and now it's over $7.” (Zaid, 07:38)
Zillow, Redfin, Rocket Companies
[08:03]
- FTC sues Zillow for antitrust violations—accused of paying Redfin $100M for exclusivity in rental listings, with Redfin agreeing to stay out of the market for nine years.
- Result: stocks for Zillow and Rocket Companies (Redfin’s parent) are sliding.
5. Memorable Moment: Bad Bunny’s Super Bowl Payout
[08:37]
- Bad Bunny announced as Super Bowl halftime headliner in Santa Clara—will be paid union minimum: about $1,000.
- “For the artist, the real payoff isn’t the money, but the exposure…over 125 million people watch the Super Bowl every year.” (Zaid, 09:05)
- NFL only covers production costs; this model has held for decades from Michael Jackson to Rihanna.
- Zaid jokes about the possibility of artists paying the NFL to perform in the future.
Notable Quotes
- “Gold is considered a safe haven… which I think is a fair description of what’s happening right now.” (Zaid, 02:07)
- “I think Nike has fully admitted defeat on their direct strategy and now they're reversing course and going back to wholesale.” (Zaid, 03:32)
- “If Nike was a basketball team… they’re about to enter the second quarter down like 15 points, but they just went on a 10–0 run.” (Zaid, 04:12)
- “Wall Street analysts don’t think that this deal will have much of an impact on Pfizer’s bottom line, since Medicaid participants already get a big discount on drugs.” (Zaid, 06:27)
- “You know, this company stock was trading at like $3 last week and now it's over $7.” (Zaid, 07:38)
- “For the artist, the real payoff isn’t the money, but the exposure… over 125 million people watch the Super Bowl every year.” (Zaid, 09:05)
Timestamps for Key Segments
| Segment | Timestamp | |----------------------------------------|---------------| | Market Recap & Gov’t Shutdown | 00:39–02:28 | | Nike Earnings & Turnaround | 02:39–05:05 | | Pfizer-Trump Drug Pricing Deal | 05:05–07:03 | | Lithium Americas Stock Surge | 07:15–08:03 | | Zillow/Redfin Antitrust Lawsuit | 08:03–08:37 | | Bad Bunny Super Bowl Fun Fact | 08:37–09:27 |
Conclusion
This fast-paced episode blends market insight, business news, and light-hearted commentary to keep investors informed. Major stories include a resilient start for Q4 despite political drama, Nike’s cautious but real turnaround, and high-profile moves in pharma and lithium. The Bad Bunny segment adds a human—and humorous—touch, showing how much The Rundown delivers in under 10 minutes.
